-
Improving Ebola virus disease outbreak control through targeted post-exposure prophylaxis Lancet Global Health (IF 19.9) Pub Date : 2024-09-10 Elin Hoffmann Dahl MD, Prof Placide Mbala PhD, Sylvain Juchet PharmD, Prof Abdoulaye Touré PhD, Alice Montoyo PharmD, Beatrice Serra MPH, Richard Kojan MD, Eric D'Ortenzio MD, Prof Bjorn Blomberg PhD, Marie Jaspard PhD
Ebola virus disease kills more than half of people infected. Since the disease is transmitted via close human contact, identifying individuals at the highest risk of developing the disease is possible on the basis of the type of contact (correlated with viral exposure). Different candidates for post-exposure prophylaxis (PEP; ie, vaccines, antivirals, and monoclonal antibodies) each have their specific
-
Microbiology testing capacity and antimicrobial drug resistance in surgical-site infections: a post-hoc, prospective, secondary analysis of the FALCON randomised trial in seven low-income and middle-income countries. Lancet Global Health (IF 19.9) Pub Date : 2024-09-05
BACKGROUND Surgical-site infection (SSI) is one of the most common health-care-associated infections, substantially contributing to antibiotic use. Targeted antibiotic prophylaxis to prevent SSIs and effective treatment are crucial to controlling antimicrobial resistance (AMR). This study aimed to describe the testing capacity and multidrug resistance (MDR) of SSI microorganisms in low-income and middle-income
-
Strengthening surgical systems in LMICs: data-driven approaches. Lancet Global Health (IF 19.9) Pub Date : 2024-09-05 Hyla-Louise Kluyts
-
Mechanisms and causes of death after abdominal surgery in low-income and middle-income countries: a secondary analysis of the FALCON trial. Lancet Global Health (IF 19.9) Pub Date : 2024-09-05
BACKGROUND Death after surgery is devasting for patients, families, and communities, but remains common in low-income and middle-income countries (LMICs). We aimed to use high-quality data from an existing global randomised trial to describe the causes and mechanisms of postoperative mortality in LMICs. To do so, we developed a novel framework, learning from both existing classification systems and
-
Correction to Lancet Glob Health 2024; 12: e1278–87 Lancet Global Health (IF 19.9) Pub Date : 2024-09-02
-
Ebola disease outbreak caused by the Sudan virus in Uganda, 2022: a descriptive epidemiological study Lancet Global Health (IF 19.9) Pub Date : 2024-08-30 Zainah Kabami MPH, Alex R Ario PhD, Julie R Harris PhD, Mackline Ninsiima MSc, Sherry R Ahirirwe MPH, Jane R Aceng Ocero MMed, Diana Atwine MMed, Henry G Mwebesa MPH, Daniel J Kyabayinze PhD, Allan N Muruta MSc, Atek Kagirita MPH, Yonas Tegegn MMed, Miriam Nanyunja PhD, Saudah N Kizito MMed, Daniel Kadobera MSc, Benon Kwesiga MPH, Samuel Gidudu MSc, Richard Migisha MPH, Issa Makumbi MSc, Daniel Eurien
Uganda has had seven Ebola disease outbreaks, between 2000 and 2022. On Sept 20, 2022, the Ministry of Health declared a Sudan virus disease outbreak in Mubende District, Central Uganda. We describe the epidemiological characteristics and transmission dynamics.
-
Addressing global micronutrient inadequacies: enhancing global data representation Lancet Global Health (IF 19.9) Pub Date : 2024-08-29 Camille Lassale, Bamba Gaye
-
Global estimation of dietary micronutrient inadequacies: a modelling analysis Lancet Global Health (IF 19.9) Pub Date : 2024-08-29 Simone Passarelli PhD, Christopher M Free PhD, Alon Shepon PhD, Ty Beal PhD, Carolina Batis PhD, Christopher D Golden PhD
Inadequate micronutrient intakes and related deficiencies are a major challenge to global public health. Analyses over the past 10 years have assessed global micronutrient deficiencies and inadequate nutrient supplies, but there have been no global estimates of inadequate micronutrient intakes. We aimed to estimate the global prevalence of inadequate micronutrient intakes for 15 essential micronutrients
-
Correction to Lancet Glob Health 2024; published online Aug 20. https://doi.org/10.1016/S2214-109X(24)00121-9 Lancet Global Health (IF 19.9) Pub Date : 2024-08-28
-
Respiratory syncytial virus infection among children younger than 2 years admitted to a paediatric intensive care unit with extended severe acute respiratory infection in ten Gavi-eligible countries: the RSV GOLD—ICU Network study Lancet Global Health (IF 19.9) Pub Date : 2024-08-28 RSV GOLD—ICU Network collaborators, Dina N Abdelrahman, Fatima L Abdullahi, Fadlulai Abdu-Raheem, Lynda T Abicher, Hamdalla Adelaiye, Ansumana Badjie, Abdou Bah, Krishna P Bista, Louis J Bont, Trisja T Boom, W Chris Buck, Milka Amanda Cáceres Avila, Ram Hari Chapagain, Daniela Cianci, Alexandra Deroncelay, Vanessa Dor, Karen Ekotto, Khalid A Enan, Charlotte Eposse, Esquivel Fouobang, Abdou Gai, Abdoulie
Patient-level data on life-threatening respiratory syncytial virus (RSV) infection in children in low-income and lower-middle-income countries (LMICs) are scarce, and this scarcity might limit demand for RSV interventions in LMICs who rely on support from Gavi, the Vaccine Alliance. We aimed to describe the characteristics of RSV-positive children younger than 2 years who were admitted to paediatric
-
RSV burden and prevention in children in LMICs Lancet Global Health (IF 19.9) Pub Date : 2024-08-28 Adam MacNeil, Meredith McMorrow
-
Paving the way for affordable and equitable liposomal amphotericin B access worldwide. Lancet Global Health (IF 19.9) Pub Date : 2024-09-01 Janice Soo Fern Lee,Rachel M Cohen,Rahela Ambaras Khan,Jessica Burry,Esther C Casas,Han Yang Chung,Luiz Henrique Costa,Nathan Ford,Diogo Lopes Nunes Galvao,Nora Giron,Joseph N Jarvis,Mousumi Mondal,Justine Jelagat Odionyi,Carmen Pérez Casas,Ajay Rangaraj,Joelle Rode,Carol Ruffell,Omar Sued,Isabela Ribeiro
Amphotericin B has long been crucial for treating many serious infectious diseases, such as invasive fungal infections and visceral leishmaniasis, particularly for patients who are immunocompromised, including those with advanced HIV infection. The conventional amphotericin B deoxycholate formulation has largely been replaced in high-income countries with liposomal amphotericin B (LAmB), which has
-
The costs and benefits of scaling up interventions to prevent poor birth outcomes in low-income and middle-income countries: a modelling study. Lancet Global Health (IF 19.9) Pub Date : 2024-09-01 Neff Walker,Austin Heuer,Rachel Sanders,Hannah Tong
BACKGROUND We estimated the benefits and costs of a set of preventive interventions that could be delivered during antenatal care to prevent poor birth outcomes, including small-for-gestational-age and preterm births. We built on the assumptions and analyses underlying the Lancet Series on small vulnerable newborns (SVNs) and extended that work by incorporating more recent data, focusing only on the
-
The global macroeconomic burden of Alzheimer's disease and other dementias: estimates and projections for 152 countries or territories. Lancet Global Health (IF 19.9) Pub Date : 2024-09-01 Simiao Chen,Zhong Cao,Arindam Nandi,Nathaniel Counts,Lirui Jiao,Klaus Prettner,Michael Kuhn,Benjamin Seligman,Daniel Tortorice,Daniel Vigo,Chen Wang,David E Bloom
BACKGROUND Alzheimer's disease and other dementias (ADODs) severely threaten the wellbeing of older people, their families, and communities, especially with projected exponential growth. Understanding the macroeconomic implications of ADODs for policy making is essential but under-researched. METHODS We used a health-augmented macroeconomic model to calculate the macroeconomic burden of ADODs for 152
-
The effect on HIV transmission and cost-effectiveness of programmes for female sex workers in East, Central, and Southern Africa: a modelling study. Lancet Global Health (IF 19.9) Pub Date : 2024-09-01 Loveleen Bansi-Matharu,Paul Revill,Issac Taramusi,Richard Steen,Sungai T Chabata,Joanna Busza,Collin Mangenah,Sithembile Musemburi,Fortunate Machingura,Nicola Desmond,Primrose Matambanadzo,Maryam Shahmanesh,Raymond Yekeye,Owen Mugurungi,Frances M Cowan,James R Hargreaves,Andrew N Phillips
BACKGROUND HIV prevalence and incidence has declined in East, Central, and Southern Africa (ECSA), but remains high among female sex workers (FSWs). Sex worker programmes have the potential to considerably increase access to HIV testing, prevention, and treatment. We aimed to quantify these improvements by modelling the potential effect of sex worker programmes at two different intensities on HIV incidence
-
Community-based strategies to increase coverage of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine in sub-Saharan Africa: a systematic review, meta-analysis, meta-ethnography, and economic assessment. Lancet Global Health (IF 19.9) Pub Date : 2024-09-01 Kadiatou Koita,Kassoum Kayentao,Eve Worrall,Anna Maria Van Eijk,Jenny Hill
BACKGROUND Community-based approaches might increase uptake of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine (IPTp-SP). We assessed the effects of community-based approaches on IPTp-SP and antenatal care coverage, and barriers and facilitators to implementation in sub-Saharan Africa. METHODS We did a systematic review, meta-analysis, meta-ethnography, and
-
Population size, HIV prevalence, and antiretroviral therapy coverage among key populations in sub-Saharan Africa: collation and synthesis of survey data, 2010-23. Lancet Global Health (IF 19.9) Pub Date : 2024-09-01 Oliver Stevens,Keith Sabin,Rebecca L Anderson,Sonia Arias Garcia,Kalai Willis,Amrita Rao,Anne F McIntyre,Elizabeth Fearon,Emilie Grard,Alice Stuart-Brown,Frances Cowan,Louisa Degenhardt,James Stannah,Jinkou Zhao,Avi J Hakim,Katherine Rucinski,Isabel Sathane,Makini Boothe,Lydia Atuhaire,Peter S Nyasulu,Mathieu Maheu-Giroux,Lucy Platt,Brian Rice,Wolfgang Hladik,Stefan Baral,Mary Mahy,Jeffrey W Imai-Eaton
BACKGROUND Key population HIV programmes in sub-Saharan Africa require epidemiological information to ensure equitable and universal access to effective services. We aimed to consolidate and harmonise survey data among female sex workers, men who have sex with men, people who inject drugs, and transgender people to estimate key population size, HIV prevalence, and antiretroviral therapy (ART) coverage
-
Improving effective coverage of medical-oxygen services for neonates and children in health facilities in Uganda: a before-after intervention study. Lancet Global Health (IF 19.9) Pub Date : 2024-09-01 Hamish R Graham,Freddy Eric Kitutu,Yewande Kamuntu,Blasio Kunihira,Santa Engol,Jasmine Miller,Absolom Zisanhi,Dorcas Kemigisha,Lorraine Nabbanja Kabunga,Charles Olaro,Harriet Ajilong,Freddie Ssengooba,Felix Lam
BACKGROUND Medical oxygen services are essential for the care of acutely unwell patients. We aimed to assess the effects of a multilevel, multicomponent health-system intervention on hypoxaemia detection, oxygen therapy, and mortality among neonates and children attending level IV health centres and hospitals in Uganda. METHODS For this before-after intervention study, we included children who attended
-
Re-evaluating the impact and cost-effectiveness of pneumococcal conjugate vaccine introduction in 112 low-income and middle-income countries in children younger than 5 years: a modelling study. Lancet Global Health (IF 19.9) Pub Date : 2024-09-01 Cynthia Chen,Gregory Ang,Katika Akksilp,Jemima Koh,J Anthony G Scott,Andrew Clark,Mark Jit
BACKGROUND Streptococcus pneumoniae has been estimated to cause 9·18 million cases of pneumococcal pneumonia, meningitis, and invasive non-pneumonia non-meningitis disease and 318 000 deaths among children younger than 5 years in 2015. We estimated the potential impact and cost-effectiveness of pneumococcal conjugate vaccine (PCV) introduction. METHODS We updated our existing pseudodynamic model to
-
Long-term effect of pneumococcal conjugate vaccines on invasive pneumococcal disease incidence among people of all ages from national, active, laboratory-based surveillance in South Africa, 2005-19: a cohort observational study. Lancet Global Health (IF 19.9) Pub Date : 2024-09-01 Anne von Gottberg,Jackie Kleynhans,Linda de Gouveia,Stefano Tempia,Susan Meiring,Vanessa Quan,Mignon du Plessis,Claire von Mollendorf,Penny Crowther-Gibson,Theunis Avenant,Nicolette du Plessis,Ranmini Kularatne,Vindana Chibabhai,Shabir A Madhi,Keith P Klugman,Cynthia G Whitney,Cheryl Cohen,
BACKGROUND In South Africa, 7-valent pneumococcal conjugate vaccine (PCV7) was introduced in 2009 and 13-valent PCV (PCV13) was introduced in 2011, both in a two plus one schedule. We evaluated the ongoing effects of PCV on the prevention of invasive pneumococcal disease (IPD) over 15 years of sustained surveillance in South Africa before the COVID-19 pandemic. METHODS We conducted national, active
-
Effectiveness and impact of monovalent rotavirus vaccination in Afghanistan: a test-negative case-control analysis. Lancet Global Health (IF 19.9) Pub Date : 2024-09-01 Palwasha Anwari,Eleanor Burnett,Najibullah Safi,Akmal Samsor,Helah Safi,Tyler P Chavers,Umesh D Parashar,Andrew D Clark,Jacqueline E Tate
BACKGROUND Afghanistan introduced monovalent rotavirus vaccine (Rotarix) into its national immunisation schedule in January, 2018. While post-licensure studies have shown substantial declines in rotavirus gastroenteritis cases and deaths globally, there is little evidence of rotavirus vaccine effectiveness and impact from low-income countries in Asia. We aimed to evaluate the effectiveness of the Rotarix
-
Prevalence of syphilis among adults and adolescents in five sub-Saharan African countries: findings from Population-based HIV Impact Assessment surveys. Lancet Global Health (IF 19.9) Pub Date : 2024-09-01 Mansoor Farahani,Rose Killian,Giles A Reid,Godfrey Musuka,Owen Mugurungi,Wilford Kirungi,Harriet Nuwagaba-Biribonwoha,Wafaa M El-Sadr,Jessica Justman
BACKGROUND HIV and syphilis are common sexually transmitted infections in sub-Saharan Africa. We aimed to investigate the prevalence and distribution of active syphilis while considering HIV status, demographic characteristics, and behavioural characteristics. METHODS The Population-based HIV Impact Assessment surveys used a cross-sectional, two-stage, stratified cluster sample design to collect data
-
Experiences of an Israeli hospital in the management of repatriated civilian hostages. Lancet Global Health (IF 19.9) Pub Date : 2024-09-01 Amir Nutman,Liron Yosha Orpaz,Shirly Oren,Yasmin Maor,Adam Lee Goldstein,Giulia Barda,Anat Levy,Zehavit Shpitzer,Liron Levinberg,Yakov Nassimov,Iliya Galbert,Michal Noah,Orna Zvi,Yaniv Fogel,Adi Shilo Kaftori,Uri Feinstein,Anat Engel
-
Improving oxygen services for children in Uganda. Lancet Global Health (IF 19.9) Pub Date : 2024-09-01 Michael T Hawkes,Sophie Namasopo
-
Assessing the prevalence and impact of preserved ratio impaired spirometry in low-income and middle-income countries: a post-hoc cross-sectional analysis. Lancet Global Health (IF 19.9) Pub Date : 2024-09-01 Trishul Siddharthan,Kyle Grealis,Nicole M Robertson,Min Lu,Sibei Liu,Suzanne L Pollard,Shakir Hossen,Peter Jackson,Natalie A Rykiel,Adaeze C Wosu,Oscar Flores-Flores,Shumonta A Quaderi,Patricia Alupo,Bruce Kirenga,Federico Ricciardi,Julie A Barber,Ram K Chandyo,Arun K Sharma,Santa Kumar Das,Laxman Shresthra,J Jaime Miranda,William Checkley,John R Hurst,
BACKGROUND More than 90% of the morbidity and mortality from chronic respiratory disease occurs in low-income and middle-income countries (LMICs), with substantial economic impact. Preserved ratio impaired spirometry (PRISm) is a prevalent lung function abnormality associated with increased mortality in high-income countries. We aimed to conduct a post-hoc analysis of a cross-sectional study to assess
-
A risk-differentiated, community-led intervention to strengthen uptake and engagement with HIV prevention and care cascades among female sex workers in Zimbabwe (AMETHIST): a cluster randomised trial. Lancet Global Health (IF 19.9) Pub Date : 2024-09-01 Frances M Cowan,Fortunate Machingura,M Sanni Ali,Sungai T Chabata,Albert Takaruza,Jeffrey Dirawo,Memory Makamba,Tsitsi Hove,Loveleen Bansi-Matharu,Primrose Matambanadzo,Maryam Shahmanesh,Joanna Busza,Richard Steen,Raymond Yekeye,Amon Mpofu,Owen Mugurungi,Andrew N Phillips,James R Hargreaves
BACKGROUND Female sex workers remain disproportionately affected by HIV. The aim of this study was to determine the effect of risk-differentiated, peer-led support for female sex workers in Zimbabwe on the risk of HIV acquisition and HIV transmission from sex among female sex workers. METHODS In this cluster randomised, open-label, controlled study, 22 clinics dedicated to female sex workers co-located
-
A look at spirometric PRISm in low-income and middle-income countries. Lancet Global Health (IF 19.9) Pub Date : 2024-09-01 Daniel Obaseki,Christian Bime,Olayemi Awopeju
-
Bridging the palliative care gap for people with rare diseases. Lancet Global Health (IF 19.9) Pub Date : 2024-09-01 Kwok Ying Chan,Shek-Kwan Richard Chang
-
The health effects and moral imperative of funding sex worker programmes. Lancet Global Health (IF 19.9) Pub Date : 2024-09-01 Minja Milovanovic,Jenny Coetzee
-
Mathematical modelling to accurately quantify the benefits of pneumococcal conjugate vaccine. Lancet Global Health (IF 19.9) Pub Date : 2024-09-01 Shrijana Shrestha,Ashis Shrestha
-
Contemporary challenges to health information for all. Lancet Global Health (IF 19.9) Pub Date : 2024-09-01 The Lancet Global Health
-
Preventive therapy: can tuberculosis efforts learn anything from the leprosy approach? Lancet Global Health (IF 19.9) Pub Date : 2024-09-01 Dominic Wakerley,Barbara de Barros,David A J Moore,Stephen L Walker,Timothy Walker,Hanif Esmail
-
LiST in the evaluation of maternal and child health programmes: a cost-effective model. Lancet Global Health (IF 19.9) Pub Date : 2024-09-01 Theresa Azonima Irinyenikan
-
Rotavirus immunisation benefits and implications in low-income countries. Lancet Global Health (IF 19.9) Pub Date : 2024-09-01 Nazish Bostan,Sadia Sattar,Sundus Javed
-
Household contact management and preventive treatment for drug-resistant tuberculosis. Lancet Global Health (IF 19.9) Pub Date : 2024-09-01 James A Seddon,Christopher F McQuaid,Nyashadzaishe Mafirakureva,Anneke C Hesseling,Greg J Fox,Peter J Dodd
-
Uncertainty in key population size estimates in sub-Saharan Africa. Lancet Global Health (IF 19.9) Pub Date : 2024-09-01 Babayemi O Olakunde,Daniel A Adeyinka
-
Primary health-care orientation of health systems in the WHO South-East Asia Region: from addressing disease to assuring health and wellbeing Lancet Global Health (IF 19.9) Pub Date : 2024-08-20 Saima Wazed, Ibadat Dhillon
-
Delivering non-communicable disease services through primary health care in selected south Asian countries: are health systems prepared? Lancet Global Health (IF 19.9) Pub Date : 2024-08-20 Prof Syed Masud Ahmed PhD, Prof Anand Krishnan PhD, Obaida Karim MPH, Prof Kashif Shafique PhD, Nahitun Naher MPH, Sanjida Ahmed Srishti B Pharm, Aravind Raj MSc, Sana Ahmed FCPS, Lal Rawal PhD, Alayne Adams PhD
In the south Asian region, delivering non-communicable disease (NCD) prevention and control services through existing primary health-care (PHC) facilities is urgently required yet currently challenging. As the first point of contact with the health-care system, PHC offers an ideal window for prevention and continuity of care over the life course, yet the implementation of PHC to address NCDs is insufficient
-
Mpox outbreaks in Africa constitute a public health emergency of continental security Lancet Global Health (IF 19.9) Pub Date : 2024-08-20 Nicaise Ndembi, Morenike Oluwatoyin Folayan, Ngashi Ngongo, Francine Ntoumi, Dimie Ogoina, Maha El Rabbat, Jean-Marie Okwo-Bele, Jean Kaseya
-
Improving urban health through primary health care in south Asia Lancet Global Health (IF 19.9) Pub Date : 2024-08-20 Krishna D Rao PhD, Mohan Bairwa MD, Akriti Mehta PhD, Sana Hyat MPH, Rushdia Ahmed MPH, Lalini Rajapaksa MD, Alayne M Adams PhD
South Asia is rapidly urbanising. The strains of rapid urbanisation have profound implications for the health and equity of urban populations. This Series paper examines primary health care (PHC) in south Asian cities. Health and its social determinants vary considerably across south Asian cities and substantial socioeconomic inequities are present. Although cities offer easy geographical access to
-
The state of primary health care in south Asia Lancet Global Health (IF 19.9) Pub Date : 2024-08-20 Shankar Prinja MD, Neha Purohit MHA, Navneet Kaur MPH, Prof Lalini Rajapaksa, Malabika Sarker PhD, Raza Zaidi MD, Sara Bennett PhD, Krishna D Rao PhD
The south Asian region (SAR) is home to 1·74 billion people, corresponding to 22% of the global population. The region faces several challenges pertaining to changing epidemiology, rapid urbanisation, and social and economic concerns, which affect health outcomes. Primary health care (PHC) is a cost-effective strategy to respond to these challenges through integrated service delivery, multi-sectoral
-
What can we learn from developments in primary health care in south Asia? Lancet Global Health (IF 19.9) Pub Date : 2024-08-20 Radhika Gore, Stephanie M Topp, Maciej Banach, Onno C P van Schayck
-
The potential distraction of a pan-regimen approach to tuberculosis Lancet Global Health (IF 19.9) Pub Date : 2024-08-16 Oxana Rucsineanu, Jennifer Furin
-
Projected health and economic effects of a pan-tuberculosis treatment regimen: a modelling study Lancet Global Health (IF 19.9) Pub Date : 2024-08-16 Theresa S Ryckman PhD, C Finn McQuaid PhD, Prof Ted Cohen DPH, Nicolas A Menzies PhD, Emily A Kendall MD
A pan-tuberculosis regimen that could be initiated without knowledge of drug susceptibility has been proposed as an objective of tuberculosis regimen development. We modelled the health and economic benefits of such a regimen and analysed which of its features contribute most to impact and savings.
-
Faith as a complex system: engaging with the faith sector for strengthened health emergency preparedness and response. Lancet Global Health (IF 19.9) Pub Date : 2024-08-06 Sarah Hess,Sally Smith,Shanmugapriya Umachandran
-
The role of humanitarian actors in global governance for AMR. Lancet Global Health (IF 19.9) Pub Date : 2024-07-26 Carine Naim,Jack Pokorny,Angela Uyen,Clare Shortall,Anna Farra,Krystel Moussally
-
From reform to excellence: the future of health care in Egypt Lancet Global Health (IF 19.9) Pub Date : 2024-07-26 Ahmed El-Sobky, Mazen Aladdin
-
Access to highly effective long-acting RSV-monoclonal antibodies for children in LMICs—reducing global inequity Lancet Global Health (IF 19.9) Pub Date : 2024-07-24 Heather J Zar, Manuele Piccolis, Jonne Terstappen, Natalie I Mazur, Lobna Gaayeb, Sébastien Morin, Louis Bont
-
WHO global research priorities for sexually transmitted infections Lancet Global Health (IF 19.9) Pub Date : 2024-07-20 Sami L Gottlieb MD, Erica Spielman MSN, Prof Laith Abu-Raddad PhD, Adeniyi Kolade Aderoba MBBS, Prof Laura H Bachmann MD, Karel Blondeel MA, Xiang-Sheng Chen MD, Tania Crucitti PhD, Gabriela Garcia Camacho BS, Sheela Godbole MD, Rodolfo Gómez Ponce de Leon PhD, Prof Somesh Gupta MD, Joumana Hermez MPH, Naoko Ishikawa MD, Prof Jeffrey D Klausner MD, Firdavs Kurbonov BS, Ismael Maatouk MD, Prof Ahmed
Sexually transmitted infections (STIs) are widespread worldwide and negatively affect sexual and reproductive health. Gaps in evidence and in available tools have long hindered STI programmes and policies, particularly in resource-limited settings. In 2022, WHO initiated a research prioritisation process to identify the most important STI research areas to address the global public health need. Using
-
Final clauses to ensure better compliance with the Pandemic Agreement Lancet Global Health (IF 19.9) Pub Date : 2024-07-19 Tae Jung Park
-
Correction to Lancet Glob Health 2024; 12: e1323–30 Lancet Global Health (IF 19.9) Pub Date : 2024-07-18
-
Africa should research the long-term sequelae of mpox Lancet Global Health (IF 19.9) Pub Date : 2024-07-17 Allan Komakech, Brian Ngongheh Ajong, Danny Kalala, Nora Efire, Cris Kacita, Emmanuel Hasivirwe Vakaniaki, Jonathan Izudi, Laurens Liesenborghs, Nicaise Ndembi
-
Hepatitis E vaccination: continued benefit for pregnant women in vulnerable settings. Lancet Global Health (IF 19.9) Pub Date : 2024-07-17 Melanie Marti,Kristine Macartney,Rebecca F Grais,Rakesh Aggarwal
-
Navigating AMR with innovative diagnostics Lancet Global Health (IF 19.9) Pub Date : 2024-07-17 The Lancet Global Health
-
Can resistance testing improve outcomes for children and adolescents with HIV? Lancet Global Health (IF 19.9) Pub Date : 2024-07-17 Julie H Levison, Catherine Orrell
-
Using verbal autopsy to enhance mortality surveillance Lancet Global Health (IF 19.9) Pub Date : 2024-07-17 Dickens Onyango, Benard Awuonda
-
A successful UN High-Level Meeting on antimicrobial resistance must build on the 2023 UN High-Level Meeting on tuberculosis Lancet Global Health (IF 19.9) Pub Date : 2024-07-17 Daniela Cirillo, Richard Anthony, Sebastien Gagneux, C Robert Horsburgh Jr, Rumina Hasan, Saffiatou Darboe, Rafael Laniado-Laborin, Ari Probandari, Nestani Tukvadze, Ricardo A Arcêncio, John S Bimba, Susanna Brighenti, Dumitru Chesov, Chen-Yuan Chiang, Gulmira Kalmambetova, Gwenan Knight, Olha Konstantynovska, Alexandra Kruse, Christoph Lange, Harriet Mayanja-Kizza, Emma McBryde, Jinsoo Min, Adrian
-
HIV incidence among women engaging in sex work in sub-Saharan Africa: a systematic review and meta-analysis Lancet Global Health (IF 19.9) Pub Date : 2024-07-17 Harriet S Jones MSc, Rebecca L Anderson BSc, Henry Cust PhD, Prof R Scott McClelland MD, Prof Barbra A Richardson PhD, Prof Harsha Thirumurthy PhD, Kalonde Malama PhD, Bernadette Hensen PhD, Prof Lucy Platt PhD, Brian Rice PhD, Prof Frances M Cowan MD, Jeffrey W Imai-Eaton PhD, Prof James R Hargreaves PhD, Oliver Stevens MSc
Women who engage in sex work in sub-Saharan Africa have a high risk of acquiring HIV infection. HIV incidence has declined among all women in sub-Saharan Africa, but trends among women who engage in sex work are poorly characterised. We synthesised data on HIV incidence among women who engage in sex work in sub-Saharan Africa and compared these with the total female population to understand relative
-
Delivering safe dengue vaccines Lancet Global Health (IF 19.9) Pub Date : 2024-07-17 Scott B Halstead
-
Over-the-counter sales of antibiotics: a call to action to ensure access and prevent excess Lancet Global Health (IF 19.9) Pub Date : 2024-07-17 Mimi (Meheret) Melles-Brewer, Francesca Chiara, Diriba Mosissa, Philip Mathew